Literature DB >> 6260386

Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor.

R Szigeti, J Luka, G Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6260386     DOI： 10.1016/0008-8749(81)90220-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  4 in total

1.  Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection.

Authors:  D Sulitzeanu; R Szigeti; G Klein; K Hennessy; E Kieff
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

2.  A prospective study on infectious mononucleosis in childhood--symptoms, serology, Epstein-Barr-Virus specific leukocyte migration inhibition.

Authors:  L Timár; J Budai; M Koller
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 3.  Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.

Authors:  G Masucci; I Berkel; M G Masucci; I Ernberg; R Szigeti; F Ersoy; O Sanal; O Yegin; G Henle; W Henle
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

4.  Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.

Authors:  R Szigeti; D Sulitzeanu; G Henle; W Henle; G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.